Current ocular GvHD (oGvHD) treatments are suboptimal. We investigated the safety and
efficacy of long-term continuous treatment with autologous platelet lysate (PL) drops in …

Background This research examined the effect of autologous serum eye drops (ASED) on
ocular symptoms, visual-related functioning and quality of life for patients failing other …

Purpose Autologous serum eye drops (ASEDs) are used worldwide to treat dry eye disease
(DED). However, the biological composition of ASEDs has not been well investigated, and …

Purpose: To determine the prevalence and manifestations of ocular graft-versus-host
disease (GvHD) after allogeneic stem cell transplantation (allo-SCT). Methods: Prospective …

This longitudinal cohort study compared ocular surface indicators in forty allogeneic
hematopoietic stem cell transplant (HSCT) subjects with twenty healthy controls at baseline …

Purpose: To evaluate the safety and efficacy of topical loteprednol etabonate (LE) 0.5%
compared with cyclosporine A (CsA) 0.05% for the prophylaxis and treatment of dry eye …

Ocular graft versus host disease (GVHD) is a common manifestation in patients undergoing
allogeneic haematopoietic stem cell transplantation (allo-HSCT). Ocular GVHD affects …

We evaluated ocular surface alterations in allogeneic hematopoietic stem cell
transplantation (HSCT) recipients with or without chronic GVHD-related dry eye in a …

AIMS To determine the incidence, natural course, and severity of dry eye occurring or
worsening after haematopoietic stem cell transplantation (SCT). METHODS At a tertiary care …

Purpose: To assess the efficacy of topical cyclosporine 0.05%(Restasis) in patients with dry
eye associated with graft versus host disease after stem cell transplantation. Methods: After …